Clinical Features and Outcomes of Mycophenolate Mofetil-induced Diarrhea: A Systematic Review
Journal Title: Journal of Advances in Medicine and Medical Research - Year 2017, Vol 24, Issue 6
Abstract
Mycophenolate Mofetil (MMF) is an immunosuppressive drug frequently used for prevention of graft rejection in solid-organ and hematopoietic stem cell transplants. MMF-induced diarrhea is a known complication, however, details regarding its clinical manifestations, treatment options, and outcomes are less clear. Differentiating MMF-induced diarrhea from other causes of diarrhea in an immunocompromised host on the basis of histology may be difficult, hence deeper clinical understanding of MMF-induced diarrhea can be valuable. Our objective was to determine the clinical manifestations and outcomes of MMF-induced diarrhea. Major databases were searched to include 44 articles that provided data on 560 episodes of diarrhea induced by MMF or its derivatives. Results depicted the median age of 45 years (range 8-70); 29% were females. The latency between use of MMF and onset of diarrhea was 990 days (range 12- 5760). Watery diarrhea was the presenting symptom in 98%. MMF was discontinued or dose reduced in 56%, switched to enteric coated mycophenolate mofetil sodium in 12%, and continued in 14%. Eighty-five percent of cases who were managed with discontinuation/dose reduction of MMF and 81% of cases who switched from MMF to enteric coated mycophenolate mofetil sodium responded. The median time to response for either change to enteric coated mycophenolate sodium or discontinuation/dose reduction of MMF was 20 days (range 1-120 days). Thus, MMF-induced diarrhea generally presents with watery diarrhea, and a majority of patients respond to discontinuation or dose reduction of MMF within a few weeks. Where continuation of MMF is important, a different drug formulation may be an option.
Authors and Affiliations
Prajwal Dhakal, Rakesh K. Gami, Adams Kusi Appiah, Smith Giri, Harlan Sayles, Vijaya R. Bhatt
Keywords
Related Articles
- EP ID EP312540
- DOI 10.9734/JAMMR/2017/37412
- Views 89
- Downloads 0
Inorganic and Organic Mercury Levels in the United States National Health and Nutrition Examination Survey (NHANES) 2005-2010
Aims: Mercury is an environmental hazard. Therefore, we studied recent trends in the blood level of organic and inorganic mercury in the United States (US). Methodology: We analyzed newly available data on blood inorgani...
A Novel Approach for Innovative Pharmaceutical, Nutraceutical and Biocosmeceutical Products: Different Types of Combination Products and Co-activation of Natural Synergistically Acting Target-Receptors (CanSATs)
Traditionally, the main model of the pharmaceutical industry for developing new drugs has been based on monotherapies, new molecular entities (NMEs), and their underlying one-target-one-disease dogma. It is no surprise t...
Risk Factors Associated with Children Missing the Fourth Dose of DTaP Vaccination
Background: In 2012, reported pertussis reached the highest number of cases (48,277) in the United States since 1955. Objectives: Estimate the prevalence of children who missed the fourth dose of DTaP (Diphtheria and Te...
What are the Sources for Health Information among Patients Attending Otolaryngology Outpatient Clinics in Israel? A Questionnaire Survey
Aim: Sources for health information are continually growing and become easily accessible to the public. The aim of the study was to investigate the sources of health information and the satisfaction level with the source...
A Complicated Case of Dyspnea
This is the case of a patient initially presenting with productive cough, pleuritic chest pain, and hypoxemia. After a complicated clinical course the patient was eventually diagnosed with mucinous adenocarcinoma of the...